20亿！强脑科技完成全球第二大单笔融资，锚定机器人的终极交互

Core Viewpoint - The article highlights the advancements in brain-computer interface technology through the example of Qiangnao Technology, which has developed a smart bionic hand that enables users to perform complex tasks, showcasing the potential for human-robot coexistence in the future [1][3]. Group 1: Company Overview - Qiangnao Technology, founded in 2015, is the first unicorn in the brain-computer interface sector in China, focusing on non-invasive brain-computer interface technology for nearly a decade [5]. - The company recently completed a financing round of approximately 2 billion yuan, making it the second-largest in the global brain-computer interface field after Neuralink [3]. Group 2: Product Development - Qiangnao Technology has launched several products, including smart bionic hands and legs, as well as brain-machine intelligent sleep devices, creating a product matrix that spans medical rehabilitation, consumer health, and advanced robotics [8]. - The smart bionic hand has been successfully used in major events such as the Beijing Winter Paralympics and the Hangzhou Asian Para Games, indicating its practical application and recognition [10]. Group 3: Technological Advancements - The company has developed a solid gel electrode that allows for convenient brain signal acquisition without the need for conductive paste, overcoming a significant barrier in non-invasive technology [7]. - Qiangnao's Revo 2 bionic hand, weighing only 383 grams, can exert a grip force of 50N and carry weights of up to 20kg, showcasing its advanced multi-modal tactile sensing capabilities [12]. Group 4: Competitive Advantage - Qiangnao Technology has established a unique technological and commercial moat through large-scale production and cost control, managing to reduce the cost of its smart bionic hand to one-fifth to one-seventh of similar products in Europe and the U.S. [15]. - The company has achieved mass production of 100,000 units of high-precision brain-computer interface products, demonstrating its capability for industrial-scale production [15]. Group 5: Future Vision - With the recent funding, Qiangnao Technology aims to accelerate technological iterations, expand into global markets, and deepen its product offerings in rehabilitation, health, and human-machine interaction [16]. - The company's strategic direction is evolving from addressing rigid medical needs to broader applications in health, targeting to assist 1 million individuals with physical disabilities and 10 million patients with Alzheimer's, autism, and sleep disorders within the next 5 to 10 years [18].